维生素D受体TaqI基因多态性与儿童肾病综合征骨代谢的相关性

崔坤华; 李琪

维生素D受体TaqI基因多态性与儿童肾病综合征骨代谢的相关性

崔坤华,
李琪

昆明医科大学第一附属医院儿科

基金项目:

基金：云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目 (AFRP2014);

计量
- 文章访问数: 2694
- HTML全文浏览量: 996
- PDF下载量: 83
- 被引次数: 0
出版历程
- 收稿日期: 2017-05-20

Correlation Between Vitamin D Receptor (VDR) TaqIGene Polymorphism and Bone Metabolism Disorder in Children, s Nephrotic Syndrome

Cui Kun Hua ,
Li Qi

Funds:

基金：云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目 (AFRP2014);

摘要

摘要: 目的研究维生素D受体TaqI基因多态性与儿童肾病综合征骨代谢标志物相关性, 以期能否根据基因多态性预测儿童骨质疏松症风险, 指导药物治疗及评估药物治疗的效果.方法研究对象为2015年5月至2016年11月收住昆明医科大学第一附属医院儿科的70例肾病综合征患儿, 维生素D受体TaqI基因多态性检测方法为PCR扩增产物酶切后琼脂糖凝胶电泳检测, 骨代谢标志物用生化分析.结果降钙素、25 (OH) D3、甲状旁腺激素、钙、磷、碱性磷酸酶在维生素D受体TaqI基因3种基因型 (TT, Tt, tt) 之间的F值分别为:0.574, 2.973, 1.947, 2.566, 0.423, 0.242, P值均大于0.05;镁在维生素D受体TaqI基因3种基因型 (TT, Tt, tt) 之间的F值9.278, P<0.001.在TT基因型患儿中, 经骨化三醇治疗2周后与治疗前骨代谢标志物对比, 降钙素、25 (OH) D3、甲状旁腺激素、镁、磷、碱性磷酸酶t值分别为:0.796, 0.290, 0.295, 0.574, 0.830, 0.933, P值均大于0.05;钙t值为4.301, P<0.001.在Tt基因型患儿中, 经骨化三醇治疗2周后与治疗前骨代谢标志物对比, 降钙素、25 (OH) D3、甲状旁腺激素、钙、镁、磷、碱性磷酸酶t值分别为:0.722, 1.298, 1.391, 1.511, 1.671, 1.045, 0.368, P>0.05.在tt基因型患儿中, 经骨化三醇治疗2周后与治疗前骨代谢标志物对比, 降钙素、25 (OH) D3、甲状旁腺激素、镁、磷、碱性磷酸酶t值分别为:1.168, 1.755, 1.787, 2.344, 1.777, 1.808, P值均大于0.05;钙t值为2.458, P<0.005.结论在肾病综合征患儿中, 维生素D受体TaqI多态性不能评估骨质疏松风险.TT基因型及tt基因型对骨化三醇治疗的反应性更好, 经骨化三醇治疗2周后血清钙较治疗前有明显的升高, 骨质疏松症的风险明显减低.
- 维生素D受体Taq I基因多态性 /
- 儿童肾病综合征 /
- 骨代谢标志物 /
- 骨化三醇 /
Abstract: Objective In this paper, we study the relationship between vitamin D receptor TaqIgene polymorphism and bone metabolism disorder in children, snephrotic syndrome, in order to predict children's risk of osteoporosisaccording to the genetic polymorphisms, guiding drug treatment and evaluating the effect of drug treatment.Methods The object of the study was the 70 cases of children with nephrotic syndrome in pediatrics in the first affiliated hospital of Kunming Medical University from May 2015 to November 2016.Genotypes of the VDR TaqI gene polymorphism were analyzed using the PCR amplification product enzyme and agarose gel electrophoresis, bone metabolic markers with biochemical analysis.Results The F value of calcitonin (CT) .25 (OH) D3 (VIT-D) .parathyroid hormone (PTH) .Calcium (Ca) .phosphorus (P) .alkaline phosphatase (ALP) in the three genotypes (TT TT TT) of vitamin D receptor TaqI gene polymorphism were:0.574, 2.973, 1.947, 2.566, 0.423, 0.242, P>0.05.The F value of magnesium (Mg) was 9.278, P<0.001.In children with TT genotype, after calcitriol treatment2 weeks, the t value of calcitonin.25 (OH) D3.parathyroidhormone.magnesium.phosphorus.alkaline phosphatase were:0.796, 0.290, 0.295, 0.574, 0.830, 0.933, P >0.05 compared with treatment before.The t value of Ca was 4.301, P<0.001.In children with Tt genotype, the t value of calcitonin.25 (OH) D3.parathyroid hormone.calcium.magnesium.phosphorus.alkaline phosphatase were:0.722, 1.298, 1.391, 1.511, 1.671, 1.045, 0.368, P>0.05.In children with tt genotype, the t value of calcitonin.25 (OH) D3.parathyroid hormone.magnesium.phosphorus.alkaline phosphatase were:1.168, 1.755, 1.787, 2.344, 1.777, 1.808, P>0.05;the t value of Ca was 2.458, the P<0.005.Conclusions In children with nephrotic syndrome, vitamin D receptor TaqI gene polymorphism can assess the risk of osteoporosis, tt genotype has lower risk of osteoporosis as compared with Tt genotype and TT genotype.TT genotype and tt genotype have better reactivity of calcitriol therapy.Serum calcium is significantly elevated after 2 weeks' treatment of calcitriol.The risk for osteoporosis is significantly reduced.
- Vitamin D receptor /
- TaqI gene polymorphism /
- Nephrotic syndrome in children /
- Bone metabolic markers /
- Calcitriol

HTML全文

参考文献(29)

[1]	[1]KHALID I, Khoshhal FRCS E D, ABOS, Childhood osteoporosis[J].Journal of Taibah University Medical Sciences, 2011, 6 (2) :61-76.
[2]	[2]LAURA K, BACHRACH M D, CATHERINE M.Bone densitometry in children and adolescents[J].Pediatrics, 2014, 26 (5) :339-346.
[3]	[3]MARK R, HANUDEL, ISIDRO B, et al.Treatment of pediatric chronic kidney disease-mineraland bone disorder[J].Curr Osteoporos Rep, 2017, 15 (3) :198-206.
[4]	[4]ONDER YAVASCAN, MD, ENGIN KOSE, MD, et al.Severe Renal Osteodystrophy in a Pediatric Patient With End-Stage Renal Disease:Sagliker Syndrome[J].Journal of Renal Nutrition the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation, 2013, 23 (4) :326-330.
[5]	[5]AKIRA ASHIDA, YUKO FUJII, Hideki Matsumura, and Hiroshi Tamai, A case of multiple vertebral compressionfractures due to glucocorticoid-inducedosteoporosis in a pediatric patient with nephrotic syndrome[J].International Journal of Clinical Pharmacology and Therapeutics, 2017, 55 (3) :264-269.
[6]	[6]SHI-YU L U, CHANG-YUAN WANG, YUE JIN, et al.The osteogenesis-promoting effects of alpha-lipoic acidagainst glucocorticoid-induced osteoporosis through the NOX4, NF-kappa B, JNK and PI3K/AKT Pathways[J].Sci Rep, 2017, 7 (1) :3331.
[7]	[7]ALESSANDRA CHESI, JONATHAN A MITCHELL, HEIDI J KALKWARF, et al.A Genomewide association study identifies two sex-specific loci, at SPTB and IZUMO3, influencing pediatric bone mineral density at multiple skeletal sites[J].J Bone Miner Res, 2017, 32 (6) :1274-1281.
[8]	[8]FRANCESCO VIERUCCI, GIUSEPPE SAGGESE, ROLANDO CIMAZ, Osteoporosis in childhood[J].Curr Opin Rheumatol, 2017, 29 (5) :535-546.
[9]	[9]SHARLA K, AMES, KENNETH J.ELLIS, et al.Vitamin D receptor gene fok1 polymorphism predicts calcium absorption and bone mineral density in children[J].J Bone Miner Res, 1999, 14 (5) :740-746.
[10]	[10] STEVEN A ABRAMS, IAN J GRIFFIN, KELI MHAWTHORNE, et al.Vitamin D receptor fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty[J].J Bone Miner Res, 2005, 20 (6) :945-953.
[11]	[11]XI W P, YANG J P, LI LQ, , et al.Association of vitamin D receptor gene Apa I polymorphism with vitamin D deficiency rickets[J].Zhonghua Er Ke Za Zhi, 2005, 43 (7) :514-516.
[12]	[12]FERRARI S, RIZZOLI R, SLOSMAN D, et al.Dietarycalcium and age explain the controversy surrounding the relationshipbetween bone mineral density and vitamin D receptorgene polymorphisms[J].J Bone Miner Res, 1998, 13 (3) :363-370.
[13]	[13]GUNNES M, BERG J P, HALSE J, et al.Lack of relationship between vitamin D receptor genotype and forearmbone gain in healthy children, adolescents, and young adults[J].J Clin Endocrinol Metab, 1997, 82 (3) :851-855.
[14]	[14]JONATHAN A, MITCHELL, DIANA L, et al.Genetics of pediatric bone strength[J].Bonekey Reports, 2016, 20 (5) :823.
[15]	[15]MONICA GROVER, LAURA K, BACHRACH.Osteoporosis in children with chronic illnesses:diagnosis, monitoring, and treatment[J].Curr Osteoporos Rep, 201, 15 (4) :271-284.
[16]金勇, 陈朝霞, 血液透析联合血液灌流治疗肾性骨营养不良的疗效[J].当代医学, 2015, 21 (25) :1009-4393.
[17]范光磊, 薄静莉, 陈杰敏, 等.慢性肾脏病患者肾性骨营养不良与骨转换生化标志物变化及相关因素分析[J].苏州大学学报 (医学版) , 2012, 32 (1) 0112-04.
[18]	[18]YAGUCHI A, TATEMICHI S, TAKEDA H, et al.PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure[J].PLo S One, 2017, 12 (7) :e0180430.
[19]	[19]SHARON M, MOE, Renal osteodystrophy or kidneyinduced osteoporosis[J].Curr Osteoporos Rep, 2017, 15 (3) :194-197.
[20]杨晓, 夏正坤, 樊忠民, 等.糖皮质激素所致儿童骨质疏松的诊断和治疗[J].医学研究生学报, 2014, 27 (2) :203-204.
[21]	[21]GHADA MOHAMED EL-MASHADA, MAHMOUD AHMED EL-HAWYA, Sally mohamed el-hefnawyb, sanaa mansour mohameda, bone mineral density in children with idiopathic nephrotic syndrome[J].J Pediatr (Rio J) , 2017, 93 (2) :142-147.
[22]	[22]ACETO G, D'ADDATO O, MESSINA G, et al.Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS[J].Pediatr Nephrol, 2014, 29 (11) :2147-2155.
[23]	[23]LEONARD M B.Glucocorticoid-induced osteoporosis in children:impact of the underlying disease[J].Pediatrics, 2007, 119 (2) :S166-174.
[24]陈晓雨, 杨伟莉, 杨建虹.镁与骨质疏松[J].中国骨质疏松杂志, 2014, 20 (9) :1125-1132.
[25]	[25]KAMAL A, GAMAL S M, ELGENGEHY F T, et al.Association of VDR apa I and taq I gene polymorphisms with the risk of scleroderma and behet's disease[J].Immunol Invest, 2016, 45 (6) :531-542.
[26]	[26]CHEN Y, WAN J X, JIANG D W, et la.Efficacy of calcitriol in treating glucocorticoidinduced osteoporosis in patients with nephrotic syndrome:an open-label, randomized controlled study[J].Clin Nephrol, 2015, 84 (5) :262-269.
[27]	[27]GULATI S, GODBOLE M, SINGH U, et al.Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease[J].Am J Kidney Dis, 2003, 41 (6) :1163-1169.
[28]	[28]BAK M, SERDAROGLU E, GUCLU R.Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome[J].Pediatr Nephrol, 2006, 21 (3) :350-354.
[29]	[29]ABRAMS S A, GRIFFIN I J, HAWTHORNE K M, et al.Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty[J].J Bone Miner Res, 2005, 20 (6) :945-953.

相关文章(20)

[1]	唐嘉黛, 谢琳, 宋红莉, 陈娇娇. 代谢综合征与胃癌发生发展的相关性研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211130
[2]	牛玲, 李博一, 毛静秋, 唐艳, 马蓉, 刘方, 张程, 韩竹君, 苗翠娟, 张娴. 维生素D受体基因多态性与昆明地区2型糖尿病伴骨质疏松症的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210711
[3]	牛玲, 李博一, 张程, 马蓉, 唐艳, 刘方, 尹利民, 韩竺君, 苗翠娟, 张娴. 降钙素受体、维生素D受体基因多态性与昆明地区2型糖尿病合并骨质疏松的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211114
[4]	阮小荟, 向茜, 王玉明, 周治含, 张弦, 郭燕, 杨晓瑞. 维生素D受体基因Bg1I、Cdx-2位点多态性与桥本氏甲状腺炎的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210824
[5]	刘阳, 王红, 袁彬彬, 关雅心, 黄世英, 左帆, 蒋世钊, 吴斌. 骨钙素基因多态性与2型糖尿病糖、脂及骨代谢指标的相关性, 昆明医科大学学报.
[6]	刘桠名, 徐冕, 颜悦新, 周凤高, 许成, 赵琨, 蒋国云, 武彧, 刘荣. 基于代谢组学的脓毒症大鼠生物标志物研究, 昆明医科大学学报.
[7]	向茜, 王玉明, 杨艳润, 李万碧, 张弦, 杨才, 刘华. 维生素D受体基因ApaI、FokI、TaqI、Tru9I位点单核苷酸多态性与桥本氏甲状腺炎的相关性, 昆明医科大学学报.
[8]	刘玉娇, 李琪. 维生素D受体基因多态性与儿童肾病综合征骨代谢异常的相关性, 昆明医科大学学报.
[9]	向茜, 李万碧, 张弦, 刘华, 王玉明, 杨才, 白云霞. 维生素D受体基因ApaⅠ、BsmⅠ位点单核苷酸多态性与2型糖尿病肾病的相关性, 昆明医科大学学报.
[10]	崔坤华, 李琪. 维生素D受体TaqI基因多态性与儿童肾病综合征激素治疗敏感性的关系, 昆明医科大学学报.
[11]	王娟. 全面护理干预对肾病综合征患者临床疗效以及并发症的影响, 昆明医科大学学报.
[12]	杜思成. 昆明地区汉族维生素D受体基因多态性与2型糖尿病的相关性, 昆明医科大学学报.
[13]	向茜. 维生素D受体基因FokI位点单核苷酸多态性与糖尿病肾病的相关性, 昆明医科大学学报.
[14]	刘瑜. 肾小管标记物对原发性肾病综合征诊断价值, 昆明医科大学学报.
[15]	向茜. 25羟维生素D与2型糖尿病肾病的关系, 昆明医科大学学报.
[16]	何琴. 阻塞性睡眠呼吸暂停低通气综合征患者的下颌骨和颞下颌关节三维有限元模型的构建, 昆明医科大学学报.
[17]	廖家贤. 灯盏细辛联合低分子肝素治疗肾病综合征的临床疗效观察, 昆明医科大学学报.
[18]	丘红梅. 代谢综合征患者胰岛素抵抗与血浆醛固酮相关性研究, 昆明医科大学学报.
[19]	李琪. 血栓通治疗小儿肾病综合征高凝状态及高脂血症的临床分析, 昆明医科大学学报.
[20]	. 维生素D受体基因多态性与汉族散发性乳腺癌的相关研究, 昆明医科大学学报.